MENU
MIST
AS OF
Dec 24 closing price
Price
$2.07
Change
+$0.12 (+6.15%)
Capitalization
176.3M
95 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
MIST
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Milestone Pharmaceuticals (MIST) Ownership - Who owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
1111 Dr. Frederik-Philips Boulevard
Phone
+1 514 336-0444
Employees
47
Web
https://www.milestonepharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
176.3M
P/E Ratio
N/A
Total Cash
82.59M
Projected Growth
N/A
Total Debt
57.21M
Revenue
N/A
Risk (Beta)
1.45
Dividend Yield
N/A
Total Cash/Share
0.97
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

MIST
Capitalization
176M
P/E Ratio
N/A
Risk (Beta)
1.45
Dividend Yield
N/A
Total Cash
82.6M
Total Cash/Share
0.97
Total Debt
57.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
20.5M
P/B Ratio
8.60
Cash Flow
N/A
Earnings
-0.79
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
312M
Current Ratio
8.24
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-54.13M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-68.07
Shares Held By Institutions
68.4M
Shares Outstanding - Current
85.2M
Total Liabilities
67.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-12.288
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
MIST
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MIST showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for MIST
A.I. Advisor
published General Information

General Information

a developer and manufacturer of cardiovascular medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1111 Dr. Frederik-Philips Boulevard
Phone
+1 514 336-0444
Employees
47
Web
https://www.milestonepharma.com